Abstract
Seborrheic dermatitis (SD) is a common skin condition highly associated with the progressive neurogenerative disorder Parkinson’s disease (PD). Conventional SD treatment typically includes topical agents; however, recent evidence suggests oral cannabidiol (CBD) may simultaneously ameliorate neurologic symptoms of PD while reducing the increased sebum production involved in SD pathogenesis. As part of a larger PD patient study, CBD treatment for SD was investigated with a parallel, double-blind randomized controlled trial collecting facial images before and after a 3-week treatment with 2.5mg/kg/day oral CBD solution (n=29) or placebo (n=29).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
